AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15837864 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream
Number of subjects: 492
Study 15837864 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 492
Study 12211219 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (400 mg/day)
Number of subjects: 16
Study 12211219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 12211219 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg) with aspirin (325 mg)
Number of subjects: 16
Study 12211219 — intervention group
Group type: COMPARATOR
Intervention: Placebo with aspirin (325 mg)
Number of subjects: 16
Study 10478142 — intervention group
Group type: EXPERIMENTAL
Intervention: BB genotype
Number of subjects: 99
Study 10478142 — intervention group
Group type: EXPERIMENTAL
Intervention: B allele and BB genotype
Number of subjects: 99
Study 10478142 — intervention group
Group type: COMPARATOR
Intervention: b allele and bb genotype
Number of subjects: 99
Study 8720887 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2 mg/kg for induction, 5-6 mg/kg.h for maintenance
Number of subjects: 230
Study 8720887 — intervention group
Group type: COMPARATOR
Intervention: Enflurane 0.8%-1.5% for maintenance
Number of subjects: 230
Study 1917320 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical isosorbide-mononitrate (ISMO) 0.5% eye drops
Number of subjects: 0
Study 1917320 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical isosorbide-mononitrate (ISMO) 2% eye drops
Number of subjects: 0
Study 31892336 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor (AI) therapy for 2 weeks
Number of subjects: 254
Study 31892336 — intervention group
Group type: COMPARATOR
Intervention: No presurgical treatment (control)
Number of subjects: 254
Study 29319719 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost negative-pressure wound therapy (USP)
Number of subjects: 0
Study 29319719 — intervention group
Group type: COMPARATOR
Intervention: Commercially available therapy device (VAC)
Number of subjects: 0
Study 25249320 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid
Number of subjects: 23
Study 25249320 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreserved human amniotic membrane (c-hAM)
Number of subjects: 23
Study 23612436 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (Ritalin, 20 mg)
Number of subjects: 19
Study 23612436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 21865456 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing Speed Training
Number of subjects: 0
Study 19365873 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-biofortified wheat (3 puffed wheat biscuits/day providing 267 microg Se)
Number of subjects: 62
Study 19365873 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-biofortified wheat
Number of subjects: 62
Study 19365873 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 62
Study 17053854 — intervention group
Group type: EXPERIMENTAL
Intervention: Acquiring syringes through a safe source
Number of subjects: 680
Study 17053854 — intervention group
Group type: EXPERIMENTAL
Intervention: Visiting a syringe exchange program
Number of subjects: 680
Study 17053854 — intervention group
Group type: COMPARATOR
Intervention: Living in San Francisco
Number of subjects: 680
Study 17053854 — intervention group
Group type: COMPARATOR
Intervention: Less frequent binge drinking
Number of subjects: 680
Study 17053854 — intervention group
Group type: COMPARATOR
Intervention: Injecting with an HIV+ partner
Number of subjects: 680
Study 17053854 — intervention group
Group type: COMPARATOR
Intervention: Peer norms supporting safe injection
Number of subjects: 680
Study 17053854 — intervention group
Group type: COMPARATOR
Intervention: Self-empowerment
Number of subjects: 680
Study 17053854 — intervention group
Group type: EXPERIMENTAL
Intervention: Being from New York
Number of subjects: 680
Study 17053854 — intervention group
Group type: EXPERIMENTAL
Intervention: Being older
Number of subjects: 680
Study 15157729 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Program (6-month behavioral skills training group)
Number of subjects: 0
Study 15157729 — intervention group
Group type: COMPARATOR
Intervention: Educational Support Program
Number of subjects: 0
Study 15157729 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 0
Study 11197295 — intervention group
Group type: EXPERIMENTAL
Intervention: Total colonic decompression
Number of subjects: 126
Study 11197295 — intervention group
Group type: COMPARATOR
Intervention: Control group (no decompression)
Number of subjects: 126
Study 9883955 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy programme
Number of subjects: 0
Study 9883955 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive training programme
Number of subjects: 0
Study 9883955 — intervention group
Group type: COMPARATOR
Intervention: General practitioner programme
Number of subjects: 0
Study 9883955 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study 8083146 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at doses of 5 mg, 10 mg, 15 mg, and 20 mg
Number of subjects: 76
Study 8083146 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 76
Study 8083146 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 76
Study 2492893 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate disodium 400 mg daily for 3 months
Number of subjects: 20
Study 2492893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2492893 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate disodium (after stopping therapy)
Number of subjects: 20
Study 2492893 — intervention group
Group type: EXPERIMENTAL
Intervention: Oophorectomy (surgical menopause)
Number of subjects: 20
Study 4851464 — intervention group
Group type: EXPERIMENTAL
Intervention: DDAVP (1-desamino-8-D-arginine vasopressin)
Number of subjects: 11
Study 4851464 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal DDAVP (twice-daily)
Number of subjects: 11
Study 4851464 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular DDAVP (single daily injections)
Number of subjects: 11
Study 4851464 — intervention group
Group type: COMPARATOR
Intervention: Lysine vasopressin
Number of subjects: 11
Study 31663925 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific, dynamic Bayesian model predicting severe oliguria
Number of subjects: 3370
Study 31663925 — intervention group
Group type: COMPARATOR
Intervention: Kidney Disease: Improving Global Outcomes urine output criterion for acute kidney injury
Number of subjects: 3370
Study 30766457 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerner EHR system
Number of subjects: 4
Study 30766457 — intervention group
Group type: COMPARATOR
Intervention: Other EHR system (not specified)
Number of subjects: 4
Study 27702805 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized booklet presenting melanoma genomic risk, telephone‐based genetic counseling, and nonpersonalized educational materials.
Number of subjects: 118
Study 27702805 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonpersonalized educational materials).
Number of subjects: 118
Study 27702805 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (personalized booklet and counseling).
Number of subjects: 118
Study 27702805 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention and control groups.
Number of subjects: 118
Study 25254570 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage with rose oil
Number of subjects: 75
Study 25254570 — intervention group
Group type: COMPARATOR
Intervention: Placebo with unscented almond oil
Number of subjects: 75
Study 25254570 — intervention group
Group type: COMPARATOR
Intervention: No treatment control (just self-massage)
Number of subjects: 75
Study 23341486 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium ranelate at 2 g/d (n = 174)
Number of subjects: 261
Study 23341486 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 87)
Number of subjects: 261
Study 21697540 — intervention group
Group type: EXPERIMENTAL
Intervention: NUTRIOSE 10 (resistant dextrin)
Number of subjects: 12
Study 21697540 — intervention group
Group type: COMPARATOR
Intervention: maltodextrin
Number of subjects: 12
Study 18289898 — intervention group
Group type: EXPERIMENTAL
Intervention: Brinzolamide suspension, 1%, dosed twice daily
Number of subjects: 78
Study 18289898 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobetaxolol suspension, 0.5%, dosed twice daily
Number of subjects: 78
Study 16510487 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecstasy users
Number of subjects: 46
Study 16510487 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 46
Study 14506909 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 100mg
Number of subjects: 20
Study 14506909 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 50mg
Number of subjects: 20
Study 10753273 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-limb training (n = 26)
Number of subjects: 67
Study 10753273 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-limb training (n = 26)
Number of subjects: 67
Study 10753273 — intervention group
Group type: COMPARATOR
Intervention: Untrained control group (n = 15)
Number of subjects: 67
Study 8827572 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction with oxytocin
Number of subjects: 123
Study 8827572 — intervention group
Group type: COMPARATOR
Intervention: Expectant care for 48 hours
Number of subjects: 123
Study 1394814 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy consisting of monthly instillations of mitomycin C and doxorubicin for 12 months
Number of subjects: 101
Study 1394814 — intervention group
Group type: COMPARATOR
Intervention: Non-maintenance group
Number of subjects: 101
Study 1394814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical combination chemotherapy (mitomycin C and doxorubicin)
Number of subjects: 101
Study 3891833 — intervention group
Group type: EXPERIMENTAL
Intervention: Octopus 2000 R perimeter
Number of subjects: 50
Study 3891833 — intervention group
Group type: EXPERIMENTAL
Intervention: Friedmann Mark II Visual Fields Analyser
Number of subjects: 50
Study 3891833 — intervention group
Group type: EXPERIMENTAL
Intervention: Baylor visual fields programmer
Number of subjects: 50
Study 30968572 — intervention group
Group type: EXPERIMENTAL
Intervention: IOL repositioning by scleral suturing
Number of subjects: 104
Study 30968572 — intervention group
Group type: COMPARATOR
Intervention: IOL exchange with a retropupillary iris-claw lens
Number of subjects: 104
Study 29567956 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediococcus acidilactici K15
Number of subjects: 0
Study 29567956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27126154 — intervention group
Group type: EXPERIMENTAL
Intervention: Between-meal snacks
Number of subjects: 247
Study 27126154 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutrition supplements (ONS)
Number of subjects: 247
Study 24953578 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral zinc sulfate (10 mg/d)
Number of subjects: 80
Study 24953578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 22088820 — intervention group
Group type: EXPERIMENTAL
Intervention: NBCA adhesive
Number of subjects: 110
Study 22088820 — intervention group
Group type: COMPARATOR
Intervention: Traditional suture
Number of subjects: 110
Study 20977764 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal focused shock wave therapy (2000 impulses, 0.25 mJ/m2 every 1-2 weeks) plus specific gluteal strength exercise training
Number of subjects: 0
Study 20977764 — intervention group
Group type: COMPARATOR
Intervention: Sham extracorporeal focused shock wave therapy (2000 impulses, 0.01 mJ/m2 every 1-2 weeks) plus specific gluteal strength exercise training
Number of subjects: 0
Study 18927173 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily) plus antioxidant capsule
Number of subjects: 1276
Study 18927173 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg daily) plus placebo capsule
Number of subjects: 1276
Study 18927173 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo tablet plus antioxidant capsule
Number of subjects: 1276
Study 18927173 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet plus placebo capsule
Number of subjects: 1276
Study 15887251 — intervention group
Group type: EXPERIMENTAL
Intervention: AC electric fields (up to 35 kV/m, frequency 60 Hz)
Number of subjects: 16
Study 15887251 — intervention group
Group type: EXPERIMENTAL
Intervention: AC electric fields limited to the dorsal forearm
Number of subjects: 16
Study 15887251 — intervention group
Group type: EXPERIMENTAL
Intervention: AC electric fields limited to the hand (hairy or glabrous skin)
Number of subjects: 16
Study 15887251 — intervention group
Group type: EXPERIMENTAL
Intervention: AC electric fields with hair removed from forearm and hand
Number of subjects: 16
Study 15887251 — intervention group
Group type: EXPERIMENTAL
Intervention: DC electric fields (up to 65 kV/m)
Number of subjects: 16
Study 11986099 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation
Number of subjects: 66
Study 11986099 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 66
Study 9708873 — intervention group
Group type: EXPERIMENTAL
Intervention: Four food-frequency categories of fruit intake
Number of subjects: 621
Study 9708873 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of fresh fruit (g/day)
Number of subjects: 621
Study 9708873 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary vitamin C intake (mg/day) measured by DR
Number of subjects: 621
Study 9708873 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 621
Study 9708873 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of vitamin C supplements
Number of subjects: 621
Study 9708873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake frequency of fruit
Number of subjects: 621
Study 9708873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake frequency of pickled vegetables
Number of subjects: 621
Study 9708873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intake frequency of potatoes
Number of subjects: 621
Study 7635771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tpot measurements (flow cytometry)
Number of subjects: 46
Study 7635771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor size
Number of subjects: 46
Study 7635771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tpot (1/Tpot)
Number of subjects: 46
Study 7635771 — intervention group
Group type: EXPERIMENTAL
Intervention: Labeling Index (LI)
Number of subjects: 46
Study 7635771 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Treatment Time (OTT)
Number of subjects: 46
Study 2359302 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples group therapy condition
Number of subjects: 16
Study 2359302 — intervention group
Group type: COMPARATOR
Intervention: Standard individual therapy condition
Number of subjects: 16
Study 314789 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile assist device (PAD)
Number of subjects: 100
Study 314789 — intervention group
Group type: COMPARATOR
Intervention: Nonpulsatile flow (Control)
Number of subjects: 100
Study 30131583 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment (exact dosage not specified)
Number of subjects: 11330
Study 30131583 — intervention group
Group type: COMPARATOR
Intervention: Other tested potential risk factors (obesity, IPS, radiotherapy)
Number of subjects: 11330
Study 29613819 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualizations that augment perceptual processing and recognition memory
Number of subjects: 90
Study 29613819 — intervention group
Group type: COMPARATOR
Intervention: Unaided team collaboration
Number of subjects: 90
Study 29613819 — intervention group
Group type: COMPARATOR
Intervention: Participant teams discussing security incidents commonly known to the majority
Number of subjects: 90
Study 26787505 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 4 mg/kg
Number of subjects: 740
Study 26787505 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 8 mg/kg
Number of subjects: 740
Study 26787505 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 740
Study 26787505 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of biomarkers
Number of subjects: 740
Study 26787505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 740
Study 24588561 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusively human milk (EHM) diet
Number of subjects: 605
Study 24588561 — intervention group
Group type: COMPARATOR
Intervention: Bovine-based milk products (control)
Number of subjects: 605
Study 22437139 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective CPAP
Number of subjects: 56
Study 22437139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 22437139 — intervention group
Group type: COMPARATOR
Intervention: OSA group
Number of subjects: 56
Study 20965879 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 11325
Study 17434829 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanic acid (2.2 g)
Number of subjects: 178
Study 17434829 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin (2 g)
Number of subjects: 178
Study 15724911 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidental encoding of temporal context; no specific dosage or duration mentioned.
Number of subjects: 0
Study 15724911 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentional encoding of temporal context; no specific dosage or duration mentioned.
Number of subjects: 0
Study 15724911 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrieval of encoding context as a cue for list occurrence; no specific dosage or duration mentioned.
Number of subjects: 0
Study 15724911 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluating temporal distance from the strength of the memory trace; no specific dosage or duration mentioned.
Number of subjects: 0
Study 12036809 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber breakfast cereal (HF diet) for 6 months
Number of subjects: 62
Study 12036809 — intervention group
Group type: COMPARATOR
Intervention: Low-fiber breakfast cereal (LF diet) for 6 months
Number of subjects: 62
Study 12036809 — intervention group
Group type: COMPARATOR
Intervention: Monounsaturated fatty acids (MUFA diet) for 6 months
Number of subjects: 62
Study 10402402 — intervention group
Group type: EXPERIMENTAL
Intervention: In-house Earle's balanced salt solution (EBSS)
Number of subjects: 448
Study 10402402 — intervention group
Group type: COMPARATOR
Intervention: Commercially prepared Earle's balanced salt solution (EBSS)
Number of subjects: 448
Study 7720336 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (0.1 g/kg)
Number of subjects: 23
Study 7720336 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (0.2 g/kg)
Number of subjects: 23
Study 7720336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 2035794 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous wound infiltration with 20 ml of 0.5% bupivacaine
Number of subjects: 28
Study 2035794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 7034564 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine plus a single dose of pyrimethamine‐sulfadoxine (Fansidar)
Number of subjects: 52
Study 7034564 — intervention group
Group type: COMPARATOR
Intervention: Quinine alone
Number of subjects: 52
Study 31931923 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual distraction (AVD) using virtual reality device (VRZ4‐VRBOX)
Number of subjects: 50
Study 31931923 — intervention group
Group type: COMPARATOR
Intervention: Topical anesthesia (benzocaine gel) without audiovisual distraction (AVD)
Number of subjects: 50
Study 30040008 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation Therapy (VRT) in conjunction with cervical spine therapy
Number of subjects: 0
Study 30040008 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation Therapy (VRT)
Number of subjects: 0
Study 30040008 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation Therapy (VRT) in conjunction with light aerobic exercise
Number of subjects: 0
Study 30040008 — intervention group
Group type: COMPARATOR
Intervention: Cervical spine therapy alone
Number of subjects: 0
Study 29097927 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-PEM
Number of subjects: 410
Study 29097927 — intervention group
Group type: COMPARATOR
Intervention: WBPET
Number of subjects: 410
Study 29097927 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-PEM (after excluding patients with lesions beyond detecting range)
Number of subjects: 410
Study 29097927 — intervention group
Group type: COMPARATOR
Intervention: WBPET (after excluding patients with lesions beyond detecting range)
Number of subjects: 410
Study 25413267 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.4% infusion
Number of subjects: 60
Study 25413267 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 60
Study 25042212 — intervention group
Group type: EXPERIMENTAL
Intervention: Quitline cessation counseling
Number of subjects: 512
Study 25042212 — intervention group
Group type: COMPARATOR
Intervention: Self-help brochure
Number of subjects: 512
Study 22795925 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipragliflozin (300 mg qd)
Number of subjects: 36
Study 22795925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 21165291 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate sodium (EC‐MPS)
Number of subjects: 258
Study 21165291 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 258
Study 21165291 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Treatment Effect (OTE) for EC‐MPS
Number of subjects: 258
Study 17329061 — intervention group
Group type: EXPERIMENTAL
Intervention: Groningen active living model (GALM) intervention group (n=79)
Number of subjects: 181
Study 17329061 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (CG) (n=102)
Number of subjects: 181